NFSG
GSK icon

Newbridge Financial Services Group’s GSK GSK Stock Holding History

Newbridge Financial Services Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Sell
4,417
-112
-2% -$5.92K 0.03% 230
2026
Q1 		$250K Buy
4,529
+530
+13% +$28.7K 0.04% 193
2025
Q4 		$196K Buy
3,999
+3,396
+563% +$158K 0.03% 234
2025
Q3 		$26K Sell
603
-51
-8% -$1.99K ﹤0.01% 677
2025
Q2 		$25.1K Buy
654
+1
+0.2% +$38 ﹤0.01% 659
2025
Q1 		$25.3K Buy
653
+444
+212% +$16.3K 0.01% 498
2024
Q4 		$7.07K Sell
209
-564
-73% -$20.3K ﹤0.01% 804
2024
Q3 		$31.6K Sell
773
-2,330
-75% -$95.3K 0.01% 312
2024
Q2 		$119K Buy
3,103
+1,963
+172% +$82.6K 0.04% 243
2024
Q1 		$48.9K Buy
+1,140
New +$47K 0.02% 399
2023
Q1 		– Sell
-339
Closed -$11.9K – 1442
2022
Q4 		$11.9K Buy
339
+320
+1,684% +$10.7K 0.01% 874
2022
Q3 		$1K Hold
19
– – ﹤0.01% 1297
2022
Q2 		$1K Buy
+19
New +$1.05K ﹤0.01% 1273

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Newbridge Financial Services Group's GSK Position: Q2 2026 in Review

Newbridge Financial Services Group reduced its GSK (GSK) stake by 2.5% in Q2 2026, selling an estimated $5.92K and leaving 4,417 shares worth $232K. The position accounts for 0.03% of the portfolio, ranked #230.

Newbridge Financial Services Group first reported a position in GSK in Q2 2022 and has held it in 13 quarters since. The position peaked at $250K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Newbridge Financial Services Group held 4,417 shares of GSK worth $232K as of Q2 2026.
  • Newbridge Financial Services Group sold 112 GSK shares in Q2 2026, an estimated $5.92K.
  • GSK made up 0.03% of Newbridge Financial Services Group's portfolio in Q2 2026, its #230 holding.
  • Newbridge Financial Services Group first reported a position in GSK in Q2 2022 and has held it in 13 quarters since.
  • Newbridge Financial Services Group's GSK position peaked at $250K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.